Effect of a Semiotically-Optimized Video Education Model on Post-Stroke Rehabilitation
NCT07709806
Brain Diseases, Cardiovascular Diseases
Siping, Jilin, China
View Trial DetailsNCT Number: NCT01846572
The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
Aggregometry result of antiplatelet therapy
Ruhr University of Bochum
Other
Prevalence of Low Response to Clopidogrel in Patients After Acute Ischemic Stroke. The Bochumer CRISP Study
Acronym: Bo-CRISP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07709806
Brain Diseases, Cardiovascular Diseases
Siping, Jilin, China
View Trial DetailsNCT05734976
Acute, Brain Diseases
Taichung, Taichung North Distrit, Taiwan
View Trial DetailsNCT03684564
Antiphospholipid Syndrome, Autoimmune Diseases
Epsom, United Kingdom
View Trial DetailsNCT06249776
Brain Diseases, Brain Infarction
Ahmedabad, Gujarat, India
View Trial Details